Senzime (Q1 Initial take): Modest sales figure due to a temporarily soft US market - Redeye
Bildkälla: Stockfoto

Senzime (Q1 Initial take): Modest sales figure due to a temporarily soft US market - Redeye

Redeye provides an initial take following Senzime’s Q1 2026 report. Sales came in below expectations during the quarter, mainly driven by a softer US market. Despite the weaker top line, the underlying business remains solid, and we view the quarter as a temporary setback rather than a change in the long-term trajectory. That said, we will publish a research update shortly, where we will lower our sales estimates.

Redeye provides an initial take following Senzime’s Q1 2026 report. Sales came in below expectations during the quarter, mainly driven by a softer US market. Despite the weaker top line, the underlying business remains solid, and we view the quarter as a temporary setback rather than a change in the long-term trajectory. That said, we will publish a research update shortly, where we will lower our sales estimates.
Börsvärldens nyhetsbrev